Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
Torex Gold Reports Q4 and Full Year 2024 Results
06:00pm, Wednesday, 19'th Feb 2025
2024 marks another solid year of operational and financial results; on track to return to positive free cash flow generation by mid-2025 (All amounts expressed in U.S. dollars unless otherwise stated)
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
04:05pm, Tuesday, 18'th Feb 2025
PLEASANTON, Calif. , Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties
03:10pm, Thursday, 13'th Feb 2025
On Wednesday, 10x Genomics Inc TXG reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of $(0.30).
10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript
08:53pm, Wednesday, 12'th Feb 2025
10x Genomics, Inc. (NASDAQ:TXG ) Q4 2024 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Cassie Corneau - Senior Director, IR and Strategic Finance Serge Saxonov - CEO and C
Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings
07:30pm, Wednesday, 12'th Feb 2025
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street e
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
06:46pm, Wednesday, 12'th Feb 2025
10x Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago.
10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
04:05pm, Wednesday, 12'th Feb 2025
PLEASANTON, Calif. , Feb. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year
Seeking Clues to 10x Genomics (TXG) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Tuesday, 11'th Feb 2025
Besides Wall Street's top -and-bottom-line estimates for 10x Genomics (TXG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during th
Cathie Wood dumped Palantir to buy these biotech stocks
08:42am, Thursday, 06'th Feb 2025
Ark Invest Management chief executive officer (CEO) Cathie Wood is a lauded yet controversial figure.
Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology
08:30am, Thursday, 06'th Feb 2025
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance researchers' understanding of cellular behavior and gene function REDWOOD CITY, Calif. , Feb. 6, 2025
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:05am, Wednesday, 05'th Feb 2025
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Torex Gold Provides Q4 2024 Update on Media Luna Project
06:00pm, Tuesday, 04'th Feb 2025
Construction substantially complete and first copper concentrate on track for March (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - February 4, 2025
Cathie Wood's Top Biotech Plays for February
07:40pm, Sunday, 02'nd Feb 2025
Don't look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns.
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Spatial Omics Market by Technology, by Product, by Workflow, by Sample Type, by End-user, and by Region" report has been added to ResearchAndMarkets.com'
10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
04:05pm, Tuesday, 28'th Jan 2025
PLEASANTON, Calif. , Jan. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and
